THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...

MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...

The National Anti-Violence and Sexual Harassment Helpline received about 11,600 calls in 2023, up from 10,800 in 2022. Read ...

A semi-detached house on Coldstream Avenue, located in the prestigious Frankel Estate in the East, has been listed for $12.3 ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The setting up of Lionheart Advocates aligns with recent efforts by the government to curb the abuse of court processes.

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...

Ben Leong, an NUS academic, has announced Lionheart Advocates, an NGO designed to assist individuals facing “frivolous ...

Berry Global Group, Inc. BERY reported first-quarter fiscal 2025 (ended December 2024) adjusted earnings of $1.09 per share, ...

On February 5, 2025, the U.S. Environmental Protection Agency (EPA) delayed until March 21, 2025, the effective date of a ...